Join us as experts discuss how flow cytometric receptor occupancy assays — when correctly implemented — are a powerful tool in modelling PK/PD relationships in the development of novel drugs.
The challenges and strategies for success in the clinical development of cell therapies.
Integrating Wearable Remote Biosensor Technology into Decentralized Clinical Trials
See how Medpace keeps trials on PACE by effectively identifying, mitigating and monitoring risk.
Known for its therapeutic excellence,
Medpace puts over 25 years of global experience to work for you.
November 15, 2021
[Webinar] Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy AssaysRead More
November 03, 2021
[On-Demand Presentation] Imaging Data QualityRead More
October 14, 2021